Entera Bio raises $275m for Phase III osteoporosis drug trial

Jul 27, 2026 | Business, Globes

The new funds from the private placement will finance the company until 2030.| Read More Front – Globes 

0 Comments

FREE ISRAEL DAILY EMAIL!

BREAKING NEWS

JNS